FDA Clearance Tracker · P990086-S001
HEALTHTRONICS OSSATRON
Last checked: Nov 20, 2026Latest source record: May 1, 2001 (this decision)Source: openFDAMethods & limitations
Decided
May 1, 2001
Approved
Time to decision
194 days
Received Oct 19, 2000. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P990086-S001
- Device name
- HEALTHTRONICS OSSATRON
- Applicant
- Sanuwave, Inc.
- Applicant location
- Alpharetta, GA
- Received
- Oct 19, 2000
- Decided
- May 1, 2001
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Postapproval Study Protocol
- Original approval
- P990086
Device type
- Device type
- Generator, shock-wave, for pain relief (NBN)
- Device class
- Class III
- Specialty
- Physical Medicine & Rehabilitation
FDA's approval statement
As written in FDA's record.
APPROVAL FOR THE POST MARKET APPROVAL STUDY PROTOCOL.
Source documents
Other decisions for Sanuwave, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- dermaPACE SystemNew device typeDe Novo
DEN160037 · Decided Dec 28, 2017 · 521 days after receipt
Device type: Extracorporeal Shock Wave Device For Treatment Of Diabetic Foot Ulcers (PZL) · General & Plastic Surgery
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.